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Abstract
Protein fibrillation is believed to play an important role in the 
pathology and development of several human diseases, such 
as Alzheimer’s disease, Parkinson’s disease and type 2 diabetes. 
Carbon dots (CDs), as a new type of nanoparticle have recently 
been extensively studied for potential biological applications, but 
their effects on protein fibrillation remain unexplored. In reality, any 
application in biological systems will inevitably have “contact” 
between proteins and CDs. In this study, human insulin was selected 
as a model protein to study the effects of CDs on protein fibrillation, as 
proteins may share a common mechanism to form fibrils. Hydrophobic 
CDs were conjugated with dihydrolipoic acid (DHLA-CDs) to facilitate 
their water solubility. Characterizations from thioflavin T fluorescence, 
circular dichroism spectroscopy and atomic force microscopy 
demonstrate that the presence of DHLA-CDs results in a higher rate 
of human insulin fibrillation, accelerating the conformational changes 
of human insulin from α-helix to β-sheet. This promoting effect is likely 
associated with the locally increased concentration of human insulin 
adsorbed on the surface of DHLA-CDs.
other research suggested that hydrophilic coated QDs accelerate the 
fibrillation of proteins (i.e., human β2-microglobulin, α-synuclein 
and human serum albumin) by enhancing the formation of the critical 
nucleus [12,13]. Our current knowledge of nanoparticles influencing 
protein fibrillation still relies on a case-by-case approach, depending 
on physical/chemical properties of proteins and nanoparticles, such 
as components, charge, coating and size [12,14,15].
Another novel type of nanoparticle-carbon dots (CDs) has recently 
arisen to replace QDs for biological applications. Compared with 
QDs, CDs are currently attracting more and more research attention 
because of their unique properties, such as excitation wavelength 
dependent photoluminescence, excellent biocompatibility, low 
cytotoxicity, and optical stability [16-18]. These properties make CDs 
increasingly attractive for applications in biological systems. Several 
studies using CDs in biological systems have shown that CDs are non-
toxic and can be used for imaging in cellular environment [16,19,20]. 
For any application of CDs in a biological system, they are inevitably 
interacting with proteins which may undergo conformational changes 
to form fibrils due to the presence of CDs. However, the effect of 
CDs on protein fibrillation has not been reported until most recently 
(March 2015) from our group [21]. In that study, water soluble CDs 
with size less than 6 nm are prepared by oxidizing carbon nano 
powder and these CDs are demonstrated to inhibit human insulin 
fibrillation in vitro in a concentration-dependent manner.
Insulin fibrils or plaques have been observed in vivo in 
patients suffering from diabetes after insulin infusion or repeated 
injection [22,23]. Insulin fibrils can be easily formed in vitro under 
certain condition, such as high concentrations, low pH and high 
temperatures [3,24]. In this study, human insulin was chosen to study 
the effects of CDs on its fibrillation. It is worth noting that the CDs 
used in this study have completely different nature from those we 
reported most recently [21] in terms of size, surface properties and 
components. The CDs in the present study have a hydrophobic core 
capped by dihydrolipoic acid (DHLA-CDs) to increase their water 
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Introduction
Formation of amyloid-like protein fibrils with cross-β-sheet 
structures from protein native conformation has been indicated to 
play an important role in the development of several serious human 
diseases, such as Alzheimer’s disease, Parkinson’s disease, prion 
diseases, and type 2 diabetes mellitus [1,2]. In spite of protein diversity 
in sources, sequences and functions, protein fibrils share strikingly 
similar characteristics, including nucleation-dependent kinetics, 
cross-β-sheet structures, elongated morphology, and thioflavin T 
(ThT) fluorescence enhancement [1,3-5]. These observations indicate 
that the fibrillation of proteins may share a common molecular 
mechanism. Therefore, study of the protein fibrillation process 
may provide useful information and insights into the pathology, 
prevention and treatment of the human diseases associated with 
protein fibrillation.
With recent nanotechnological developments in nanomedicine and 
biomedical engineering, much attention is focused on understanding 
the interaction and toxicity of nanomaterials on cellular components, 
such as proteins, plasma membranes and DNA [6-10]. Quantum dots 
(QDs), a class of typical nanoparticles, have been extensively studied 
with proteins to explore their potential biomedical applications. One 
study illustrated that N-acetyl-L-cysteine capped CdTeQDs inhibit 
amyloid beta 1-40 fibril formation in vitro [11]. On the contrary, 
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solubility. Furthermore, the size of DHLA-CDs is much larger than 
6 nm. Different concentrations of these DHLA-CDs were added to 
human insulin to study the kinetics of its fibrillation. These samples 
were subsequently characterized by fluorescence spectroscopy of 
thioflavin T and circular dichroism spectroscopy. The morphology 
of fibrils was monitored visually by atomic force microscopy (AFM). 
Our investigation demonstrates that the presence of DHLA-CDs 
promotes human insulin fibrillation.
Experimental Section
Materials
Recombinant human insulin, (±)-α-lipoic acid (also known as 
DL-thioctic acid), 1-octadecene and thioflavin T wereobtained from 
MP Biomedicals, LLC (Solon, OH). 1-Hexadecylamine, citric acid 
and other chemicals were reagent grade and purchased from Sigma-
Aldrich (St. Louis, MO). The deionized water was obtained from a 
Modulab 2020 water purification system (San Antonio, TX).
Synthesis of hydrophobic carbon dots
Hydrophobic carbon dots were synthesized with the procedure 
developed by Wang et al. [25]. A mixture of 15 mLof1-octadecene 
and 1.5 g of1-hexadecylamine was heated in a three-neck flask under 
argon flow to 300 °C, and then 1 g of citric acid was injected into the 
mixture. The solution was kept at 300 °C for 3hours. After reaction, 
it was cooled down in air to room temperature. The solid form of 
hydrophobic carbon dots was obtained and purified by precipitating 
with acetone in an ice bath. It was further characterized by UV-vis 
absorption (Shimadzu UV-2600, Japan), fluorescence (Fluorolog-3, 
Horiba JobinYvon, Edison, NJ), Fourier transform infrared 
spectroscopy (PerkinElmer, Frontier), and atomic force microscopy 
(Agilent 5420, Santa Clara, CA).
Synthesis of DHLA conjugated carbon dots (DHLA-CDs)
Dihydrolipoic acid (DHLA) was synthesized by reducing 
(±)-α-lipoic acid with sodium borohydride in an ice bath and the 
product was extracted by chloroform using the same procedures 
developed by Clapp et al. [26]. 0.2 g of as-prepared hydrophobic 
carbon dots and 1 g of DHLA were added into a12 mL mixture 
consisting of methanol and chloroform (1:1, v/v), and heated at 60 °C 
for 4 hours. Potassium tert-butoxide was added to basify the solution 
and the mixture was centrifuged at 2500 rpm for 15 min to obtain 
precipitates, which were water soluble DHLA conjugated carbon dots 
(DHLA-CDs). The product was further characterized by spectroscopy 
of UV-vis, FTIR, fluorescence, atomic force microscopy (AFM) and 
transmission electron microscopy (TEM).
Characterization of human insulin fibrillation 
Human insulin was dissolved in hydrochloric acid aqueous 
solution (pH 1.6) with 100Mm sodium chloride to a concentration 
of 1 mg/mL and incubated at 37 °C with stirring in a sand bath [27]. 
Insulin/DHLA-CDs mixture samples were also prepared at the same 
concentration of protein in the presence of 0.2 or 2 µg/mL of DHLA-
CDs. Aliquots of samples were withdrawn at various time periods and 
characterized for fibril formation with the following methods. 
Thioflavin T (ThT) fluorescence was recorded on a Fluorolog-3 
spectrofluorometer at an excitation wavelength of 450 nm in a quartz 
cuvette with 1 cm optical path length. Aliquots of protein solutions 
were diluted with ThT solution to 0.1 mg/mL of protein and 20 µM 
of ThT. In all measurements of fluorescence, emission and excitation 
slit widths were set at 5 nm. The experiments were repeated three 
times and average emission intensity at 485 nm was plotted against 
incubation time.
Circular dichroism spectra were obtained on a JASCO J-810 
spectropolarimeter (Easton, MD). The spectra were recorded between 
190 and 260 nm at room temperature employing a 2 mm optical path 
length quartz cell. The spectra were measured using diluted aliquots 
(to 0.1 mg/mL of insulin) withdrawn from the human insulin or 
insulin/DHLA-CDs mixture solutions. 
Atomic force microscopy images were taken with tapping 
mode by an Agilent 5420 AFM instrument (Santa Clara, CA) with 
a resolution of 512×512 pixels. The cantilever had a resonance 
frequency of ~170 kHz with typical force constant of 7.5 N/m. The 
sample was drop-coated on a freshly cleaved mica slide and allowed 
to dry. Then the sample coated mica slide was gently washed with 
pure water to remove the salt and allowed to air dry. Transmission 
electron microscopy (TEM) image of DHLA-CDs was obtained on a 
JEOL 1200X TEM.
Results and Discussion
Characterization of hydrophobic CDs and DHLA-CDs
The hydrophobic carbon dots were synthesized using the 
procedure reported by Wang et al. [25]. The as-prepared hydrophobic 
carbon dots are soluble in chloroform and highly fluorescent under 
365 nm UV lamp (Figure 1A). The UV-vis absorption spectrum 
contains a peak at about 360 nm (Figure 1B). The maximal 
fluorescence emission peak of these carbon dots is dependent on 
the excitation wavelength (Figures 1C and 1D), and it shifts toward 
higher wavelengths when excited at larger wavelengths. The size of 
the prepared hydrophobic CDs is about 6-8 nm based on atomic force 
microscopy imaging. All these characterizations are consistent with 
the results reported before [25].
CDs were conjugated with DHLA to increase their water 
solubility. After preparation, the DHLA-CDs were characterized by 
FTIR, UV-Vis, fluorescence and AFM (Figure 2). As displayed in 
Figure 2A, the absorbance peaks of the carboxyl group at 1705 cm-1 in 
CDs and DHLA vanished after conjugation, while a weak peak around 
1017 cm-1 appeared in DHLA-CDs. These observations suggest the 
formation of a thioester. Compared with CDs in chloroform, the 
UV-vis absorption peak of DHLA-CDs in water becomes weaker 
and blue shifted to about 325 nm (Figure 2B). In addition, the 
maximal fluorescence intensity of DHLA-CDs in aqueous solution 
becomes much smaller after conjugation compared to that of CDs in 
chloroform at the same concentration (i.e. 0.15 mg/mL, Figure 2C). 
It is worth noting that the sharp peaks in Figure 2C are caused by 
the Raman scattering. The fluorescence emission peak is the broad 
one neighboring the Raman scattering peaks. Compared to the 
strong emission of the core (Figure 1C), the reduced fluorescence of 
DHLA-CDs is likely due to the presence of DHLA outside the surface 
of the hydrophobic core of CDs, modifying the surface passivation 
of CDs. The atomic force microscopy (AFM) image in Figure 2D 
illustrates the morphology of CDs after conjugation, which shows the 
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Figure 1: (A) Hydrophobic carbon dots dissolved in chloroform under regular light or 365 nm UV lamp; (B) UV-vis absorption of hydrophobic carbon dots at 0.8 
mg/mL in chloroform; (C) Fluorescence spectra of hydrophobic carbon dots at 0.15 mg/mL in chloroform under various excitation wavelengths; (D) Normalized 
fluorescence spectra.
Figure 2: (A) FTIR spectra of hydrophobic carbon dots (CDs), DHLA, and DHLA conjugated CDs (DHLA-CDs); (B) UV-vis absorption of DHLA–CDs in water; (C) 
Fluorescence emission spectra of 0.15 mg/mL DHLA-CDs in water (i.e. the broad peaks neighboring the Raman scattering) under various excitation wavelengths; 
(D) AFM and (E) TEM image of DHLA-CDs.
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height profile ranging from 12 to 20 nm. The transmission electron 
microscopy (TEM) image in Figure 2E displays that the sizes of the 
particles are between 10 to 30 nm.
Thioflavin T fluorescence of human insulin incubated with 
DHLA-CDs
Human insulin solutions were incubated at a constant insulin 
concentration of 1 mg/mL in 100 mM NaCl solution at pH 1.6 in the 
absence or presence of DHLA-CDs at 37 °C. It has been previously 
reported that human insulin is able to form fibrils in vitro under 
these ionic strength, pH and temperature conditions [27]. Similar to 
the fibrillation of other proteins, it is proposed that human insulin 
undergoes its fibrillation process through a three-state transition: (1) 
a lag phase, (2) an initiation stage where fibril formation starts taking 
place and increases rapidly with time and (3) the final saturation 
phase which features a plateau of mature fibril formation [28,29]. 
Figure 3 exhibits thioflavin T (ThT) fluorescence of human insulin 
in the absence and presence of DHLA-CDs (i.e. 0, 0.2 and 2 µg/mL). 
The intensity of fluorescence emission of ThT at 485 nm increases 
with incubation time, indicating the formation of insulin fibrils [30-
32]. All the samples containing human insulin show an increase 
in fluorescence intensity with the time of incubation, while 2 µg/
mL DHLA-CDs alone does not display ThT fluorescence intensity 
increase at 485 nm with the time of incubation. For the insulin sample 
(black curve in Figure 3), a well-defined lag time is observed where 
there is no significant increase in ThT fluorescence intensity at 485 
nm for the first 4 hours of incubation. After the first 4 hours, a gradual 
increase in intensity is observed, which reaches a plateau after about 
6 hours of incubation. However, in the presence of 0.2 or 2 µg/mL 
of DHLA-CDs, an increase of fluorescence intensity at 485 nm is 
observed at the beginning (red and blue curves in Figure 3). The lag 
phase time is significantly reduced in the presence of DHLA-CDs. At 
each time period of incubation, higher concentrations of DHLA-CDs 
have greater ThT fluorescence intensity, suggesting that the presence 
of more DHLA-CD results in a higher rate of insulin fibrillation.
Secondary conformational changes of human insulin 
incubated with DHLA-CDs
Circular dichroism is a spectroscopic technique widely used 
to characterize conformational changes of proteins and peptides 
[33-35]. In the experiment, the conformational changes of human 
insulin in the absence and presence of DHLA-CDs were monitored 
with circular dichroism spectroscopy during the fibrillation process. 
Figures 4A-4C shows the spectra of aliquots withdrawn at incubation 
times of 0, 3.5 and 6 hours, respectively. In the absence and presence 
of DHLA-CDs, human insulin at time 0 has almost exactly the same 
circular dichroism spectra with two negative bands at 208 and 222 
nm, which are characteristics of the α-helix conformation (Figure 
4A). After 3.5 hours of incubation, the peak at 208 nm becomes 
weaker and a broad band around 218 nm begins to appear, indicating 
that the secondary conformation changes from α-helix to β-sheet 
(Figure 4B). It is worth noting that human insulin at time 3.5 hours 
in the presence of DHLA-CDs experiences a larger conformational 
change than that in the absence of DHLA-CDs based on the ellipticity 
at 218 nm. After 6 hours of incubation, human insulin changes to 
β-sheet in all cases (Figure 4C).
Circular dichroism spectra in Figure 4 indicate that all human 
insulin samples are transformed to a β-sheet conformation 
with increasing time of incubation. However, the rate of this 
transformation increases in the presence of DHLA-CDs. Therefore, 
the circular dichroism spectra illustrate that the rate of insulin’s 
β-sheet transformation takes place in a shorter amount of time when 
DHLA-CDs are present.
AFM imaging analysis
AFM images of samples were analyzed at 30 minutes time 
intervals throughout the incubation process to monitor progress 
of fibril formation. Figure 5 displays the AFM images of samples at 
incubation time intervals of 0, 0.5, 3.5 and 6 hours. At time 0, all three 
samples exhibit no fibril formation. The next sample was taken at 0.5 
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Figure 3: Normalized thioflavin T (ThT) fluorescence intensity at 485 nm of 10-fold diluted samples against incubation time in the absence and presence of DHLA-
CDs. The original samples contained 1 mg/mL of human insulin with 0 (black), 0.2 (red) or 2 (blue) µg/mL of DHLA-CDs. The green curve is a control experiment 
with 2 µg/mL of DHLA-CDs mixed with ThT. The excitation wavelength was 450 nm.
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Figure 4: Circular dichroism spectra of human insulin incubated in the absence and presence of DHLA-CDs for (A) 0, (B) 3.5 and (C) 6 hours. The original samples 
contained 1 mg/mL of human insulin with 0 (black), 0.2 (red) or 2 µg/mL (blue) of DHLA-CDs. The concentration of human insulin was diluted to 0.1 mg/mL in all 
cases to obtain circular dichroism spectra. It is worth noting that the whole circular dichroism spectrum of 2 µg/mL DHLA-CDs alone is around 0 (data not shown).
Figure 5: AFM images of samples at incubation times of 0, 0.5, 3.5 and 6 hours: (A) insulin in the absence of DHLA-CDs; (B) insulin with 0.2 µg/mL of DHLA-CDs; 
(C) insulin with 2 µg/mL of DHLA-CDs. The scale bar shows 1 µm.
hours after incubation at 37 °C. The topography of the human insulin 
sample in the absence of DHLA-CDs looks similar to that at time 0. 
This sample does not show the formation of fibrils until 3.5 hours 
of incubation (Figure 5A). However, insulin fibrils are observed after 
30 minutes of incubation in the presence of DHLA-CDs with height 
10 ~ 20 nm and length 0.5 ~ 2 µm (Figures 5B-5C). Based on these 
observations, protofibrils are expected to form during the first 30 
minutes of incubation in the presence of DHLA-CDs. From AFM 
images, it is difficult to judge whether the proto fibrils or fibrils bind to 
or grow from the particles of DHLA-CDs. All three samples were next 
measured at 6 hours and they all demonstrated the presence of fibrils. 
Therefore, the AFM images also confirm that the presence of DHLA-
CDs increases the rate of human insulin fibrillation by shortening the 
lag phase time. Mature insulin fibrils are observed within 30 minutes 
of incubation in the presence of DHLA-CDs, whereas it takes about 
3.5 hours for insulin fibrils to appear in the absence of DHLA-CDs. 
Discussion
It is widely accepted that the typical protein fibrillation process 
involves a number of intermediate states, including nucleation, 
oligomerization, and fibril formation [3,28,29,36]. The formation of 
the nucleation species (also called lag phase) is the key rate-determining 
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step, as it is a thermodynamically unfavored process during 
protein fibrillation. It has been known recently that the presence of 
nanoparticles can significantly affect protein conformation as a result 
of the interactions between nanoparticles and proteins [12,14,15,21]. 
Therefore, it is not unexpected that the presence of nanoparticles 
may accelerate or inhibit protein fibrillation. Although extensive 
studies are now being carried out on the effects of nanoparticles on 
protein fibrillation, our current knowledge still relies on a case-by-
case approach [37]. In general, the effects are due to the interaction 
between proteins and the surface of nanoparticles, depending on the 
protein surface properties (charge, stability, hydrophobicity), and on 
the nanoparticle characteristics (charge, size, coating, components) 
[12,14,15,37].
In the present study, an accelerating effect on human insulin 
fibrillation, by shortening the lag phase time, was observed in 
the presence of DHLA-CDs. Although the detailed molecular 
mechanism of nucleation on the surface of these nanoparticles 
remains elusive, the fibrillation process is believed to be associated 
with the locally increased concentration of insulin in the vicinity 
of the nanoparticle surface due to the adsorption [12,38-40]. It is 
worth noting that the adsorption is likely from weak interactions, 
such as hydrophobic interaction, hydrogen bonding and electrostatic 
interaction. Among them, the major contributor is expected to be the 
hydrophobic interaction between human insulin and the surface of 
DHLA-CDs. The surface of the core of CDs and the carbon chain 
of DHLA are both hydrophobic, providing a hydrophobic interface 
for the insulin adsorption. Similar to the scenario of insulin at a 
hydrophilic-hydrophobic interface, the insulin monomers unfold 
the native conformations followed by the adsorption [3,41-43]. This 
process facilitates the subsequent assembly of disordered oligomeric 
structures. Thereafter, these assemblies undergo a process of re-
ordering into β-sheet structures, which are driven by hydrogen 
bonding formation [40].
The enhanced fibrillation effect was more obvious at higher 
concentrations of DHLA-CDs under the same concentration of 
human insulin. Parameters of nanoparticles under this condition 
were the same, such as surface charge, coating, and surface curvature. 
The main difference may come from the total surface area available 
on DHLA-CDs for insulin adsorption. Upon adsorption, the insulin 
monomers unfold the conformations, which facilitate the formation 
of insulin oligomers. At higher concentrations of DHLA-CDs, larger 
surface areas are available for unfolding insulin monomers, thus 
generating more oligomers. The continuing assembly of oligomers 
will produce more nuclei. Once the critical concentration of 
nucleation is reached, elongation of insulin fibrils will rapidly occur.
Most recently we reported that water soluble fluorescent CDs 
with an average diameter of 4 nm were prepared by a “top-down” 
approach from oxidizing carbon nanopowder. Our experiments 
demonstrated that these CDs strongly inhibit human insulin 
fibrillation in a concentration–dependent manner [21]. Increasing 
the concentration of CDs enhances the inhibiting effect. On the 
contrary, the presence of the DHLA-CDs in this study promotes 
human insulin fibrillation in a concentration-dependent manner. 
One has to point out that the DHLA-CDs have completely different 
nature in terms of size, surface property and component from those 
we reported in Reference [21]. As displayed in Figure 2D and 2E, the 
size of the DHLA-CDs is much larger (i.e. 10~30 nm) than those water 
soluble fluorescent CDs. Strictly speaking, the DHLA-CDs should not 
be called carbon dots any more due to the large size. Furthermore, 
the DHLA-CDs have a hydrophobic core capped by dihydrolipoic 
acid which has a long nonpolar carbon chain. On the other hand, 
the surface of the CDs used in Reference [21] is highly hydrophilic 
with plenty of carboxylic groups. To summarize, we believe that these 
differences of size, surface property and component determine the 
opposite observations on human insulin fibrillation. As mentioned in 
the introduction, our current knowledge of nanoparticles influencing 
protein fibrillation still relies on a case-by-case approach [12,14,15]. 
Conclusions
Protein fibrillation has been found to play a significant role in 
several human diseases, such as Alzheimer’s disease, Parkinson’s 
disease and type 2 diabetes. Some nanoparticles have been shown 
to have potential applications in nanomedicine and biomedical 
engineering due to their interactions with proteins. Carbon dots, 
as a new type of nanoparticle, have been extensively studied for 
their applications in biological systems, but their effects on protein 
fibrillation remain elusive. In this study, DHLA-conjugated carbon 
dots were synthesized by capping the hydrophobic core with 
dihydrolipoic acid. Their effect on human insulin fibrillation was 
investigated in vitro by incubation at 37 °C. The experiments illustrate 
that the presence of DHLA-CDs results in a higher rate of human 
insulin fibrillation, accelerating the secondary conformational 
change of human insulin from α-helix to β-sheet. This promoting 
effect of DHLA-CDs may be associated with the locally increased 
concentration of human insulin adsorbed on their surface and 
conformational changes after adsorption.
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